These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2525328)

  • 1. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris.
    Camm AJ; Maltz MB
    Am J Cardiol; 1989 Jun; 63(21):61J-65J. PubMed ID: 2525328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris.
    Meany TB; Richardson P; Camm AJ; Coltart J; Griffith M; Maltz MB; Signy M
    Am J Cardiol; 1989 Jun; 63(21):66J-70J. PubMed ID: 2525329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.
    Kinoshita M; Hashimoto K; Ohbayashi Y; Inoue T; Taguchi H; Mitsunami K
    Am J Cardiol; 1989 Jun; 63(21):71J-74J. PubMed ID: 2525330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.
    Hayata N; Araki H; Nakamura M
    Am Heart J; 1986 Dec; 112(6):1245-50. PubMed ID: 2947447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.
    Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH
    Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
    Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL; Blin P; Peterlongo F
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.
    Di Somma S; Liguori V; Petitto M; Carotenuto A; Bokor D; de Divitiis O; de Divitiis M
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):119-23. PubMed ID: 8485067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of nicorandil and atenolol in stable angina pectoris.
    Hughes LO; Rose EL; Lahiri A; Raftery EB
    Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina.
    Chen JW; Lee WL; Hsu NW; Lin SJ; Ting CT; Wang SP; Chang MS
    Am J Cardiol; 1997 Jul; 80(1):32-8. PubMed ID: 9205016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris.
    Kinoshita M; Nishikawa S; Sawamura M; Yamaguchi S; Mitsunami K; Itoh M; Motomura M; Bito K; Mashiro I; Kawakita S
    Am J Cardiol; 1986 Oct; 58(9):733-8. PubMed ID: 2945420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and therapeutic effects of nicorandil.
    Kinoshita M; Sakai K
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1075-88. PubMed ID: 2150592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nicorandil on exercise performance in patients with effort angina: a multicenter trial using a treadmill exercise test.
    Kato K; Asanoi H; Wakabayashi C; Hosoda S; Shiina A; Hosono K; Kurita A; Seki K; Ishida K; Kuroiwa A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S98-103. PubMed ID: 2447432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
    Raftery EB; Lahiri A; Hughes LO; Rose EL
    Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
    Lai C; Onnis E; Solinas R; Orani E; Lai G; Cadeddu M; Cherchi A
    Cardiologia; 1991 Sep; 36(9):703-11. PubMed ID: 1839369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.